Your Followed Topics

Top 1 apogee pharmaceuticals News Today

#1
Key facts: Blackstone to fund Apogee $1.3B; backs Ksi Lisims
#1 out of 186.56%
business1h ago

Key facts: Blackstone to fund Apogee $1.3B; backs Ksi Lisims

  • Blackstone agrees to fund Apogee with up to $1.3 billion, combining $800 million royalty-style financing and $500 million in debt.
  • The deal includes 15-year, tiered royalties as part of Apogee funding.
  • Blackstone also backs the Ksi Lisims project, with talks with additional European buyers underway.
  • Construction could start as early as late 2026 if long-term sales deals and lender support are secured.
  • The funding supports a planned phase 3 in H2 2026 for Apogee, per the report.
  • The deal is described in TradingView News as a key fact regarding Blackstone’s funding actions.
  • The report notes ongoing talks with European buyers for Ksi Lisims are underway.
  • Apogee's funding aims to support a phase 3 development milestone in the latter half of 2026.
  • The arrangement includes royalty-style financing and debt components for Apogee.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement